Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA3230441
Max Phase: Preclinical
Molecular Formula: C20H32N2O7
Molecular Weight: 322.45
Molecule Type: Small molecule
Associated Items:
ID: ALA3230441
Max Phase: Preclinical
Molecular Formula: C20H32N2O7
Molecular Weight: 322.45
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CCCCCC(=O)Nc1ccc(OCC(O)CNC(C)C)cc1.O=C(O)C(=O)O
Standard InChI: InChI=1S/C18H30N2O3.C2H2O4/c1-4-5-6-7-18(22)20-15-8-10-17(11-9-15)23-13-16(21)12-19-14(2)3;3-1(4)2(5)6/h8-11,14,16,19,21H,4-7,12-13H2,1-3H3,(H,20,22);(H,3,4)(H,5,6)
Standard InChI Key: WMQNKIWPTSGPSZ-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 322.45 | Molecular Weight (Monoisotopic): 322.2256 | AlogP: 2.94 | #Rotatable Bonds: 11 |
Polar Surface Area: 70.59 | Molecular Species: BASE | HBA: 4 | HBD: 3 |
#RO5 Violations: 0 | HBA (Lipinski): 5 | HBD (Lipinski): 3 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: | CX Basic pKa: 9.67 | CX LogP: 2.87 | CX LogD: 0.64 |
Aromatic Rings: 1 | Heavy Atoms: 23 | QED Weighted: 0.55 | Np Likeness Score: -0.79 |
1. Rzeszotarski WJ, Gibson RE, Eckelman WC, Reba RC.. (1979) Cardioselectivity of beta-adrenoceptor blocking agents 1. 1-[(4-Hydroxyphenethyl)amino]-3-(aryloxy)propan-2-ols., 22 (6): [PMID:37339] [10.1021/jm00192a022] |
Source(1):